1. Indian J Med Paediatr Oncol. 2013 Jul;34(3):159-63. doi: 
10.4103/0971-5851.123712.

Report of chronic myeloid leukemia in chronic phase from All India Institute of 
Medical Sciences, 1990-2010.

Mishra P(1), Seth T(1), Mahapatra M(1), Saxena R(1).

Author information:
(1)Department of Hematology, All India Institute of Medical Sciences, New Delhi, 
India.

All India Institute of Medical Sciences is an Apex Institute and caters more 
than 1.5 million out-patients and 80,000 in-patients every year. In this study, 
they have presented interesting results of patients treated with interferon, 
interferon plus cytarabine and then with imatinib plus cytarabine. They have 
presented data of 525 patients treated on imatinib alone. Imatinib dose was 
increased in 56 (10.6%) patients and regain of complete hematological response 
was seen in 26 patients. A total of 14 patients were transplanted for different 
indications of chronic myeloid leukemia and out of which 12 patients are doing 
well, while two died due to Grade IV gut graft-versus-host disease.

DOI: 10.4103/0971-5851.123712
PMCID: PMC3902613
PMID: 24516298

Conflict of interest statement: Conflict of Interest: None declared.